Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fangfang Liu

Showing results (421-430 of 535) with videos related to

Pageof 54
Sort By:
Molecular Carcinogenesis|May 18, 2019
Purpurogallin is a novel mitogen-activated protein kinase kinase 1/2 inhibitor that suppresses esophageal squamous cell carcinoma growth in vitro and in vivoXiaomeng Xie, Xueyin Zu, Feifei Liu, et al.
Oncotarget|September 24, 2017
Incidence and clearance of oral human papillomavirus infection: A population-based cohort study in rural ChinaChaoting Zhang, Fangfang Liu, Yaqi Pan, et al.
Scientific Reports|July 24, 2015
Transmission of genital human papillomavirus infection in couples: a population-based cohort study in rural ChinaMengfei Liu, Zhonghu He, Chanyuan Zhang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 3, 2018
Viral Load in the Natural History of Human Papillomavirus Infection Among Men in Rural China: A Population-based Prospective StudyMengfei Liu, Fangfang Liu, Yaqi Pan, et al.
Scientific Reports|November 20, 2020
A prediction model for outcome in patients with HBV-ACLF based on predisposition, injury, response and organ failureFangfang Liu, Zhengsheng Zou, Lijun Shen, et al.
Eclinicalmedicine|March 15, 2021
Estimating cancer survival and prevalence with the Medical-Insurance-System-based Cancer Surveillance System (MIS-CASS): An empirical study in ChinaHongrui Tian, Yanjun Hu, Qingxiang Li, et al.
Frontiers in Oncology|April 7, 2022
Economic Burden Conferred by Population-Level Cancer Screening on Resource-Limited Communities: Lessons From the ESECC TrialFuxiao Li, Yanjun Hu, Chuanhai Guo, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|February 7, 2022
Development and validation of a questionnaire-based risk scoring system to identify individuals at high risk for gastric cancer in Chinese populationsRen Zhou, Hongchen Zheng, Mengfei Liu, et al.
Cancer Biology & Medicine|April 24, 2021
sLe<sup>x</sup> expression in invasive micropapillary breast carcinoma is associated with poor prognosis and can be combined with MUC1/EMA as a supplementary diagnostic indicatorYawen Song, Hui Sun, Kailiang Wu, et al.
Nature Communications|December 26, 2025
SREBP1-mediated lipogenesis promotes dedifferentiation and senescence of vascular smooth muscle cells through epigenetic remodelingBowen Li, Kaixiang Zhou, Anan Yin, et al.
Pageof 54

Showing results (421-430 of 535) with videos related to

Sort By:
Pageof 54
Molecular Carcinogenesis|May 18, 2019
Purpurogallin is a novel mitogen-activated protein kinase kinase 1/2 inhibitor that suppresses esophageal squamous cell carcinoma growth in vitro and in vivoXiaomeng Xie, Xueyin Zu, Feifei Liu, et al.
Oncotarget|September 24, 2017
Incidence and clearance of oral human papillomavirus infection: A population-based cohort study in rural ChinaChaoting Zhang, Fangfang Liu, Yaqi Pan, et al.
Scientific Reports|July 24, 2015
Transmission of genital human papillomavirus infection in couples: a population-based cohort study in rural ChinaMengfei Liu, Zhonghu He, Chanyuan Zhang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 3, 2018
Viral Load in the Natural History of Human Papillomavirus Infection Among Men in Rural China: A Population-based Prospective StudyMengfei Liu, Fangfang Liu, Yaqi Pan, et al.
Scientific Reports|November 20, 2020
A prediction model for outcome in patients with HBV-ACLF based on predisposition, injury, response and organ failureFangfang Liu, Zhengsheng Zou, Lijun Shen, et al.
Eclinicalmedicine|March 15, 2021
Estimating cancer survival and prevalence with the Medical-Insurance-System-based Cancer Surveillance System (MIS-CASS): An empirical study in ChinaHongrui Tian, Yanjun Hu, Qingxiang Li, et al.
Frontiers in Oncology|April 7, 2022
Economic Burden Conferred by Population-Level Cancer Screening on Resource-Limited Communities: Lessons From the ESECC TrialFuxiao Li, Yanjun Hu, Chuanhai Guo, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|February 7, 2022
Development and validation of a questionnaire-based risk scoring system to identify individuals at high risk for gastric cancer in Chinese populationsRen Zhou, Hongchen Zheng, Mengfei Liu, et al.
Cancer Biology & Medicine|April 24, 2021
sLe<sup>x</sup> expression in invasive micropapillary breast carcinoma is associated with poor prognosis and can be combined with MUC1/EMA as a supplementary diagnostic indicatorYawen Song, Hui Sun, Kailiang Wu, et al.
Nature Communications|December 26, 2025
SREBP1-mediated lipogenesis promotes dedifferentiation and senescence of vascular smooth muscle cells through epigenetic remodelingBowen Li, Kaixiang Zhou, Anan Yin, et al.
Pageof 54